Olexandr Dybkov

3.0k total citations
36 papers, 2.1k citations indexed

About

Olexandr Dybkov is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Olexandr Dybkov has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Olexandr Dybkov's work include RNA Research and Splicing (27 papers), RNA and protein synthesis mechanisms (26 papers) and RNA modifications and cancer (19 papers). Olexandr Dybkov is often cited by papers focused on RNA Research and Splicing (27 papers), RNA and protein synthesis mechanisms (26 papers) and RNA modifications and cancer (19 papers). Olexandr Dybkov collaborates with scholars based in Germany, United Kingdom and United States. Olexandr Dybkov's co-authors include Henning Urlaub, Reinhard Lührmann, Holger Stark, Berthold Kastner, Dmitry E. Agafonov, Cindy L. Will, Klaus Hartmuth, Karl Bertram, Jana Schmitzová and David Haselbach and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Olexandr Dybkov

35 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olexandr Dybkov Germany 22 2.0k 80 77 72 71 36 2.1k
Dmitry E. Agafonov Germany 20 1.6k 0.8× 62 0.8× 74 1.0× 64 0.9× 164 2.3× 26 1.8k
Wojciech P. Galej France 17 1.4k 0.7× 49 0.6× 70 0.9× 98 1.4× 35 0.5× 24 1.5k
Paolo Swuec Italy 15 759 0.4× 101 1.3× 48 0.6× 23 0.3× 95 1.3× 24 857
Daniel H. Lin United States 11 929 0.5× 111 1.4× 27 0.4× 69 1.0× 64 0.9× 14 1.1k
Clemens Plaschka Austria 13 1.0k 0.5× 41 0.5× 55 0.7× 58 0.8× 55 0.8× 18 1.2k
Patrizia Fabrizio Germany 33 3.0k 1.5× 45 0.6× 52 0.7× 17 0.2× 72 1.0× 42 3.1k
Ruixue Wan China 17 1.7k 0.9× 69 0.9× 65 0.8× 92 1.3× 24 0.3× 22 1.8k
Virginie Ropars France 20 830 0.4× 48 0.6× 38 0.5× 30 0.4× 88 1.2× 42 1.1k
C.H.S. Aylett United Kingdom 17 937 0.5× 30 0.4× 95 1.2× 57 0.8× 174 2.5× 26 1.2k
Philipp Milkereit Germany 27 2.2k 1.1× 44 0.6× 74 1.0× 23 0.3× 87 1.2× 52 2.3k

Countries citing papers authored by Olexandr Dybkov

Since Specialization
Citations

This map shows the geographic impact of Olexandr Dybkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olexandr Dybkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olexandr Dybkov more than expected).

Fields of papers citing papers by Olexandr Dybkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olexandr Dybkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olexandr Dybkov. The network helps show where Olexandr Dybkov may publish in the future.

Co-authorship network of co-authors of Olexandr Dybkov

This figure shows the co-authorship network connecting the top 25 collaborators of Olexandr Dybkov. A scholar is included among the top collaborators of Olexandr Dybkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olexandr Dybkov. Olexandr Dybkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soni, Komal, Attila Horváth, Olexandr Dybkov, et al.. (2025). Structures of aberrant spliceosome intermediates on their way to disassembly. Nature Structural & Molecular Biology. 32(5). 914–925. 3 indexed citations
2.
Ochmann, Moritz, et al.. (2024). Structural basis of Integrator-dependent RNA polymerase II termination. Nature. 629(8010). 219–227. 33 indexed citations
3.
Möller, Ulrike, Christiane Spillner, S. König, et al.. (2024). Phosphorylation of ELYS promotes its interaction with VAPB at decondensing chromosomes during mitosis. EMBO Reports. 25(5). 2391–2417. 3 indexed citations
4.
Dybkov, Olexandr, Cindy L. Will, Sebastian Ludwig, et al.. (2024). Structural insights into the cross-exon to cross-intron spliceosome switch. Nature. 630(8018). 1012–1019. 10 indexed citations
5.
Chen, Ying, Goran Kokić, Christian Dienemann, et al.. (2023). Structure of the transcribing RNA polymerase II–Elongin complex. Nature Structural & Molecular Biology. 30(12). 1925–1935. 10 indexed citations
6.
Chen, Ying, Christian Dienemann, Olexandr Dybkov, et al.. (2021). Structural basis of Integrator-mediated transcription regulation. Science. 374(6569). 883–887. 95 indexed citations
7.
Linden, A., Piotr Neumann, Alexander Benjamin Schendzielorz, et al.. (2021). Mapping protein interactions in the active TOM-TIM23 supercomplex. Nature Communications. 12(1). 5715–5715. 43 indexed citations
8.
Dybkov, Olexandr, Jean‐Baptiste Fourmann, Cindy L. Will, et al.. (2021). Structural insights into how Prp5 proofreads the pre-mRNA branch site. Nature. 596(7871). 296–300. 39 indexed citations
9.
Zhang, Zhenwei, Cindy L. Will, Karl Bertram, et al.. (2020). Molecular architecture of the human 17S U2 snRNP. Nature. 583(7815). 310–313. 72 indexed citations
10.
Schweimer, Kristian, Lu Yu, Theodoros I. Roumeliotis, et al.. (2019). Autoinhibition Mechanism of the Ubiquitin-Conjugating Enzyme UBE2S by Autoubiquitination. Structure. 27(8). 1195–1210.e7. 21 indexed citations
11.
Moura, Tales Rocha de, Sina Mozaffari‐Jovin, Jana Schmitzová, et al.. (2018). Prp19/Pso4 Is an Autoinhibited Ubiquitin Ligase Activated by Stepwise Assembly of Three Splicing Factors. Molecular Cell. 69(6). 979–992.e6. 31 indexed citations
12.
Bertram, Karl, Dmitry E. Agafonov, Olexandr Dybkov, et al.. (2017). Cryo-EM structure of a human spliceosome activated for step 2 of splicing. Nature. 542(7641). 318–323. 186 indexed citations
13.
Said, Nelly, E. A. Anedchenko, Karine Santos, et al.. (2017). Structural basis for λN-dependent processive transcription antitermination. Nature Microbiology. 2(7). 17062–17062. 52 indexed citations
14.
Bertram, Karl, Dmitry E. Agafonov, Olexandr Dybkov, et al.. (2017). Cryo-EM Structure of a Pre-catalytic Human Spliceosome Primed for Activation. Cell. 170(4). 701–713.e11. 187 indexed citations
15.
Agafonov, Dmitry E., Berthold Kastner, Olexandr Dybkov, et al.. (2016). Molecular architecture of the human U4/U6.U5 tri-snRNP. Science. 351(6280). 1416–1420. 155 indexed citations
16.
Rauhut, Reinhard, Patrizia Fabrizio, Olexandr Dybkov, et al.. (2016). Molecular architecture of the Saccharomyces cerevisiae activated spliceosome. Science. 353(6306). 1399–1405. 148 indexed citations
17.
Ohrt, Thomas, Olexandr Dybkov, Nicolas Rasche, et al.. (2012). Prp2-mediated protein rearrangements at the catalytic core of the spliceosome as revealed by dcFCCS. RNA. 18(6). 1244–1256. 71 indexed citations
18.
Yu, Yang, Patricia A. Maroney, John A. Denker, et al.. (2008). Dynamic Regulation of Alternative Splicing by Silencers that Modulate 5′ Splice Site Competition. Cell. 135(7). 1224–1236. 107 indexed citations
19.
Dybkov, Olexandr, et al.. (2007). Improved identification of enriched peptide RNA cross-links from ribonucleoprotein particles (RNPs) by mass spectrometry. Nucleic Acids Research. 35(15). e95–e95. 17 indexed citations
20.
Spadaccini, Roberta, Olexandr Dybkov, Cindy L. Will, et al.. (2006). Biochemical and NMR analyses of an SF3b155–p14–U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing. RNA. 12(3). 410–425. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dmitry E. Agafonov Breakdown of academic impact, for papers by Wojciech P. Galej Breakdown of academic impact, for papers by Paolo Swuec Breakdown of academic impact, for papers by Daniel H. Lin Breakdown of academic impact, for papers by Clemens Plaschka Breakdown of academic impact, for papers by Patrizia Fabrizio Breakdown of academic impact, for papers by Ruixue Wan Breakdown of academic impact, for papers by Virginie Ropars Breakdown of academic impact, for papers by C.H.S. Aylett Breakdown of academic impact, for papers by Philipp Milkereit
Rankless by CCL
2026